Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-06-06
1998-03-17
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514109, 514129, 514535, A61K 31255
Patent
active
057287317
ABSTRACT:
The oligomers of the present invention are polyamides having a number average molecular weight of <10,000. These oligomers are water-soluble, have a rigid backbone with a predictable anion spacing, and are pharmaceutically-acceptable. The oligomers are useful for the treatment and/or diagnosis of HSV and HCMV.
REFERENCES:
patent: 2833744 (1958-05-01), Neher
patent: 3528949 (1970-09-01), Rutledge
patent: 4471110 (1984-09-01), Christell
patent: 4604404 (1986-08-01), Munson et al.
patent: 4783446 (1988-11-01), Neushul
patent: 4824916 (1989-04-01), Kershner et al.
patent: 4895660 (1990-01-01), Kershner et al.
patent: 4966894 (1990-10-01), Herr et al.
patent: 5424063 (1995-06-01), Cardin et al.
Vandenberg E.J. et al., Polymeric Matericals Science and Engineering, vol. 57, Fall Meeting 1987, pp. 139-143.
R.M. Ottenbrite, ACS Symposium Series #186, pp. 205-220 (1982) "The Antitumor and Antiviral Effects of Polycarboxylic Acid Polymers".
G. Odian, Principles of Polymerization, 2d, pp. 20-25 (1981).
Ahmed, et al., Antiviral Chemistry & Chemotherapy, (1995) "Potent Inhibition of Herpes Simplex Virus by MDL101028 a Novel Biphenyl Disulphonic Acid Co-polymer".
Antiviral Research, 19 (1992) Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors, Prem Mohan, et al., pp. 139-150.
Cardin et al., "Stilbene Disulfonic Acids. CD4 Antagonists that Block Human Immunodeficiency Virus Type-1 Growth at Multiple Stages of the Viral Like Cycle" J. Biol. Chem (1991), 266(20), 1335563.
Hofferek et al., Chemical Abstracts vol. 114: 180333q (1990).
Akerfeldt, et al., Chemical Abstracts vol. 75: 72945H (1971).
Taylor et al, "Potent Inhibition of Human Immunodeficiency Virus (HIV) by MDL 101028, a Novel Supphonic Acid Polymer", 1995.
Antiviral Research, 18 (1992), Sulfonic acid polymers as a new class of human immunodefi-ciency virus inhibitors, Prem Mohan, et al., pp. 139-150.
Cardin Alan D.
Jackson Richard L.
Mullins Michael J.
Kimble Karen L.
Kumar Shailendra
Merrell Pharmaceuticals Inc.
Nesbitt Stephen L.
The Dow Chemical Co.
LandOfFree
Anti-herpes virus and cytomegalovirus polyamide oligomers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-herpes virus and cytomegalovirus polyamide oligomers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-herpes virus and cytomegalovirus polyamide oligomers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-958094